Clinical Trial Update: Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma. [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial comparing 18F-MFBG PET/CT to 123I-MIBG SPECT imaging in pediatric patients with neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• [123I]-MIBG (Iodine-123 labeled MIBG (123I-MIBG))
• [18F]-MFBG (18F-MFBG)

Snippet

Sponsor: Institut Curie | Conditions: Neuroblastoma | Phase 2 | Status: NOT_YET_RECRUITING